APA (7th ed.) Citation

Gobeil, É., Maltais-Payette, I., Taba, N., Brière, F., Ghodsian, N., Abner, E., . . . Arsenault, B. J. (2022, May). Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites.

Chicago Style (17th ed.) Citation

Gobeil, Émilie, et al. "Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease." Metabolites May. 2022.

MLA (9th ed.) Citation

Gobeil, Émilie, et al. "Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease." Metabolites, May. 2022.